GlassScriptPhysician profile
Robyn L Roberts
NPI 1427377001
$36,906.83
in general payments reported to CMS, 2019-2025
23 companies · $620 in 2025
The $620 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,173 · 2020: $15K · 2021: $11K · 2022: $6,386 · 2023: $383 · 2024: $405 · 2025: $620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,402 · Education: $5.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,402.43 |
| Education | $5.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $34,680.08 | 2019-2024 | |
| Axonics, INC. | $264.64 | 2020-2024 | Axonics |
| Boston Scientific Corporation | $241.98 | 2019-2025 | Axonics, General - Erectile Dysfunction, General - Female Sui |
| Galderma Laboratories, L.P. | $189.96 | 2020-2022 | |
| Astellas Pharma US INC | $184.02 | 2019-2022 | |
| Ge Healthcare | $162.06 | 2025 | |
| Immunitybio, INC. | $144.43 | 2025 | |
| Avanos Medical | $143.57 | 2024 | On-Q* Pump and Accessories |
| Coloplast Corp | $142.79 | 2020-2022 | |
| Teleflex LLC | $124.98 | 2021-2024 | Urolift |
| Abbvie INC. | $114.56 | 2023-2025 | Botox |
| Revance Therapeutics, INC. | $98.70 | 2025 | Daxxify |
| Neotract INC. | $92.77 | 2019-2020 | |
| Halozyme INC | $63.28 | 2023 | |
| Medtronic, INC. | $41.53 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $40.43 | 2020-2021 | |
| Janssen Biotech, INC. | $39.08 | 2023 | Erleada |
| 180 Medical, INC. | $35.71 | 2019-2024 | |
| Merz North America, INC. | $25.40 | 2025 | |
| Endo Pharmaceuticals INC. | $24.80 | 2019-2021 | |
| Antares Pharma, INC. | $21.13 | 2024 | Xyosted |
| Glaxosmithkline, LLC. | $16.06 | 2019 | |
| Dentsply Ih INC. | $14.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robyn Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.